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EDITORIALInduction of Autophagy: A Novel Anti-inﬂammatory Function
of High-Density Lipoproteinhe inverse relationship between plasma high-Tdensity lipoprotein (HDL) cholesterol levels and
the risk for development of atherosclerotic cardiovascular
disease has led to extensive studies of HDL and its major
apoprotein apolipoprotein A-I (apoA-I) with respect to
their antiatherogenic role. The ability of HDL and apoA-I to
promote the efﬂux of cholesterol from cells in peripheral
tissues, including macrophages in atherosclerotic plaques,
and to transport the cholesterol to the liver for excretion
via biliary secretion is considered their major atheropro-
tective role. However, HDL and apoA-I also have other
functions that impact cardiovascular disease and other
disorders, including diabetes, autoimmune dysfunction,
and neurodegeneration. The activities of HDL are derived
from its antioxidant, anti-inﬂammatory, and antiapoptotic
properties.
Much of the anti-inﬂammatory effect of apoA-I and HDL
is thought to be mediated by modulation of the cholesterol
content of membrane lipid rafts due to their promotion of
cholesterol efﬂux via ATP-binding cassette subfamily A
member 1 (ABCA1), ATP-binding cassette subfamily G
member 1 (ABCG1), and scavenger receptor class B type I
(SR-BI). The article in this issue of Cellular and Molecular
Gastroenterology and Hepatology by Gerster et al1 has
demonstrated that HDL also protects the colon from
inﬂammation, providing insight into a novel mechanism by
which HDL exerts its anti-inﬂammatory effect.
Using apoA-I knockout and transgenic mouse models,
the investigators have demonstrated a protective effect by
HDL/apoA-I on colitis induced by dextran sodium sulfate or
2,4,6-trinitrobenzenesulfonic acid. In vitro studies using
pharmacologic manipulations or genetic knock down in a
colonic epithelial cell line indicate that HDL and apoA-I
induce autophagy via inhibition of the mammalian target
of rapamycin (mTOR), a negative regulator of autophagy,
that leads to the trafﬁcking of phosphorylated IkB kinase
(p-IKK) to the autophagosome for degradation and the
consequent attenuation of nuclear factor kB (NF-kB)-
mediated expression of proinﬂammatory genes. The anti-
inﬂammatory role of the induction of autophagy by HDL
was further conﬁrmed using mucosal ﬁbroblasts from pa-
tients with a Crohn’s disease polymorphism of the
autophagy-related gene ATG16L1.
Although HDL has been shown to interfere with NF-kB-
mediated transcription of proinﬂammatory genes, the mo-
lecular mechanisms are not well understood. This study
identiﬁes the induction of autophagy by HDL and the
recruitment of p-IKK, which is necessary for the activation
of NF-kB, to autophagosomes as a novel mechanism medi-
ating the anti-inﬂammatory function of HDL. The induction
of autophagy by HDL is somewhat surprising. SeveralCellustudies have implicated HDL/apoA-I in the activation of the
phosphoinositide 3-kinase/protein kinase B (PI3K-Akt)
pathway via SR-BI or sphingosine-1-phosphate (S1P) re-
ceptors. Because PI3K-Akt is a positive regulatory of mTOR,
it might have been anticipated that HDL would inhibit
autophagy.
What mechanism(s) may be involved in the induction of
autophagy by HDL, and why should HDL induce autophagy?
The study by Gerster et al suggests that the HDL induction
of autophagy is independent of the promotion of cellular
cholesterol efﬂux. HDL attenuation of tumor necrosis factor-
mediated inﬂammation in T84 colonic epithelia was not
affected by small interfering RNA (siRNA)-mediated down-
regulation of SR-BI and ABCG1 expression, the two major
proteins mediating efﬂux to HDL. Although apoA-I is the
major apoprotein on HDL, recent proteomic and lipidomic
analyses have revealed that HDL contains a diverse protein
content and contains a number of minor bioactive lipids,
including sphingosine-1-phosphate, that function in
signaling pathways. One or more of these proteins or lipid
cargo may interact with cell surface or intracellular
receptors.
An intracellular function cannot be ruled out, as HDL
was shown to be localized in autophagosomes. Thus, the
induction of autophagy may function to bring important
protein components of HDL, such as enzymes capable of
degrading oxidized lipids, or bioactive lipids into the cells,
which in turn may contribute to the decrease in cellular
inﬂammation.
Interestingly, lipid-free apoA-I also attenuated the tumor
necrosis factor-mediated inﬂammation. This might argue
that all of the signaling mediated by HDL may be via apoA-I
and not by its lipid or other protein cargo. However, lipid-
free apoA-I mediates cholesterol efﬂux via interaction with
ABCA1 not ABCG1 or SR-BI. Because the small interfering
RNA (siRNA)-mediated ABCA1 knock down in T84 cells was
not efﬁcient, cholesterol efﬂux cannot be completely excluded
as a mechanism of apoA-I anti-inﬂammatory activity.
Finally, the investigators demonstrate that increases
induced by dextran sodium sulfate or 2,4,6-trini-
trobenzenesulfonic acid in mucosal myeloperoxidase (MPO)
activity are attenuated in apoA-I transgenic mice. Given that
MPO can act on apoA-I and impairs apoA-I and HDL func-
tion, it is intriguing to speculate that MPO-mediated modi-
ﬁcations may trigger HDL trafﬁcking to the autophagosome
and autophagy, resulting in clearance of these functionally
impaired HDL particles and making way for intact HDL to
reduce inﬂammation.
The study by Gerster et al1 demonstrates a novel
mechanism mediating the anti-inﬂammatory effect of HDL,
namely, via the induction of autophagy and the trafﬁcking oflar and Molecular Gastroenterology and Hepatology 2015;1:123–124
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strates that HDL has a role in modulating inﬂammation in
the colon. Although further mechanistic studies are needed,
this study has added to the complexity of HDL functions.
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